نتایج جستجو برای: progressive multiple sclerosis

تعداد نتایج: 887581  

2017
Jennifer M Charlesworth Evelyn McManus

Through an examination of the life of an 83-year-old patient diagnosed clinically with secondary progressive multiple sclerosis (MS), general practice specialists, consultants and junior doctors will see the importance of assessing their patient's concept of health and how to use this understanding to target healthcare options within their healthcare system. This article highlights, in a resour...

Journal: :Current opinion in neurology 2015
Ilana Katz Sand

PURPOSE OF REVIEW The increasing availability of effective therapies for multiple sclerosis as well as research demonstrating the benefits of early treatment highlights the importance of expedient and accurate multiple sclerosis diagnosis. This review will discuss the classification, diagnosis, and differential diagnosis of multiple sclerosis. RECENT FINDINGS An international panel of multipl...

Journal: :Brain 2009
Josa M. Frischer Stephan Bramow Assunta Dal-Bianco Claudia F. Lucchinetti Helmut Rauschka Manfred Schmidbauer Henning Laursen Per Soelberg Sorensen Hans Lassmann

Some recent studies suggest that in progressive multiple sclerosis, neurodegeneration may occur independently from inflammation. The aim of our study was to analyse the interdependence of inflammation, neurodegeneration and disease progression in various multiple sclerosis stages in relation to lesional activity and clinical course, with a particular focus on progressive multiple sclerosis. The...

2015
F Davies A Edwards K Brain M Edwards R Jones R Wallbank N P Robertson F Wood

OBJECTIVES Although the transition to secondary progressive multiple sclerosis (SPMS) is known to be a period of uncertainty for clinicians, who may find progressive disease challenging to objectively identify, little research has explored the experiences of patients and carers specifically during this transition period. Our objective was to explore what patients and their carers understand abo...

Journal: :Brain : a journal of neurology 2016
Johannes Lorscheider Katherine Buzzard Vilija Jokubaitis Tim Spelman Eva Havrdova Dana Horakova Maria Trojano Guillermo Izquierdo Marc Girard Pierre Duquette Alexandre Prat Alessandra Lugaresi François Grand'Maison Pierre Grammond Raymond Hupperts Raed Alroughani Patrizia Sola Cavit Boz Eugenio Pucci Jeanette Lechner-Scott Roberto Bergamaschi Celia Oreja-Guevara Gerardo Iuliano Vincent Van Pesch Franco Granella Cristina Ramo-Tello Daniele Spitaleri Thor Petersen Mark Slee Freek Verheul Radek Ampapa Maria Pia Amato Pamela McCombe Steve Vucic José Luis Sánchez Menoyo Edgardo Cristiano Michael H Barnett Suzanne Hodgkinson Javier Olascoaga Maria Laura Saladino Orla Gray Cameron Shaw Fraser Moore Helmut Butzkueven Tomas Kalincik

A number of studies have been conducted with the onset of secondary progressive multiple sclerosis as an inclusion criterion or an outcome of interest. However, a standardized objective definition of secondary progressive multiple sclerosis has been lacking. The aim of this work was to evaluate the accuracy and feasibility of an objective definition for secondary progressive multiple sclerosis,...

Journal: :Iranian journal of allergy, asthma, and immunology 2013
Maryam Izad Mohammad Hossein Harirchian Hamed Amiri Farangis Najafi Zahra Ghaflati Zahra Salehi

Cumulating evidence points to a key role for CD8+ T cells in the pathogenesis of multiple sclerosis.CD8 expression level was believed to be present constantly on the surface of human peripheral blood T cells. However, it was shown that peripheral blood lymphocytes may be divided by the level of CD8 expression, into CD8+high and CD8+low T cells. Now it is well established that the CD8low populat...

2017
Adrian - Minh Schumacher Christoph Mahler Martin Kerschensteiner

Multiple sclerosis (MS) is a common inflammatory disease of the nervous system that generally starts in young adulthood and over time frequently leads to progressive functional deficits. A characteristic of this still puzzling disease is that its clinical manifestation changes as it progresses. Although during the early phases of the disorder, most patients mainly experience relapses, on averag...

Malihe Hassan nia, Nafise Bahrami, Yasaman Behmanesh, Zahra Ghane,

Multiple sclerosis is an autoimmune disease caused by damage to the myelin of the nerve cells in the spinal cord and brain, MS was classified into 4 types including: Relasping/remitting (RR) primary/progressive (PP), secondary/progressive (SP), progressive/relapsing (PR). PR MS is one of the severe forms of MS that lead to inflammation associated physical, mental and vision dysfunction. Because...

Journal: :International journal of MS care 2016
Freya Davies Fiona Wood Katherine E Brain Michelle Edwards Rhiannon Jones Rachel Wallbank Neil P Robertson Adrian Edwards

Background: Identifying the transition from relapsing-remitting to secondary progressive multiple sclerosis (SPMS) can be challenging for clinicians. Little previous research has explored how professionals experience working with patients during this specific stage of the disease. We explored the experiences of a group of multidisciplinary professionals who support patients in the transition to...

Journal: :Journal of neurology, neurosurgery, and psychiatry 2003
M-L Sumelahti P J Tienari M Hakama J Wikström

OBJECTIVE To compare the secular trends and geographical differences in the incidence of relapsing-remitting (RRMS) and primary progressive multiple sclerosis (PPMS) in Finland, and to draw inferences about aetiological differences between the two forms of the disease. METHODS New multiple sclerosis cases in southern Uusimaa and the western districts Vaasa and Seinäjoki of Finland in 1979-199...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید